These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8203857)

  • 1. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
    Broun ER; Wheat JL; Kneebone PH; Sundblad K; Hromas RA; Tricot G
    Antimicrob Agents Chemother; 1994 Mar; 38(3):576-9. PubMed ID: 8203857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    JAMA; 1994 Oct; 272(15):1183-9. PubMed ID: 7933348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis.
    Arns da Cunha C; Weisdorf D; Shu XO; DeFor T; Pastor JD; Johnson JR
    Bone Marrow Transplant; 1998 Jan; 21(2):173-80. PubMed ID: 9489635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of streptococcal bacteraemia with oral penicillin V in children undergoing bone marrow transplantation.
    Castagnola E; Lanino E; Garaventa A; Dini G; Dallorso S; Carrega G; Viscoli C
    Support Care Cancer; 1995 Sep; 3(5):319-21. PubMed ID: 8520880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
    Kern WV; Hay B; Kern P; Marre R; Arnold R
    Antimicrob Agents Chemother; 1994 Mar; 38(3):465-72. PubMed ID: 8203838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.
    Classen DC; Burke JP; Ford CD; Evershed S; Aloia MR; Wilfahrt JK; Elliott JA
    Am J Med; 1990 Oct; 89(4):441-6. PubMed ID: 2171333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin.
    Teinturier C; Hartmann O; Lemerle J; Benhamou E; Maraninchi D
    Pediatr Hematol Oncol; 1995; 12(1):73-7. PubMed ID: 7703045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
    Cruciani M; Rampazzo R; Malena M; Lazzarini L; Todeschini G; Messori A; Concia E
    Clin Infect Dis; 1996 Oct; 23(4):795-805. PubMed ID: 8909847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
    Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
    Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.
    Cruciani M; Malena M; Bosco O; Nardi S; Serpelloni G; Mengoli C
    J Clin Oncol; 2003 Nov; 21(22):4127-37. PubMed ID: 14615441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.
    de Jong P; de Jong M; Kuijper E; van der Lelie J
    Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):750-5. PubMed ID: 8307043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.
    Vassilomanolakis M; Plataniotis G; Koumakis G; Hajichristou H; Skouteri H; Dova H; Efremidis AP
    Bone Marrow Transplant; 1995 Jan; 15(1):77-80. PubMed ID: 7742759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
    Spanik S; Trupl J; Kunova A; Botek R; Sorkovska D; Grey E; Studena M; Lacka J; Oravcova E; Krchnakova A; Rusnakova V; Svec J; Krupova I; Grausova S; Stopkova K; Koren P; Krcmery V
    Scand J Infect Dis; 1997; 29(3):245-9. PubMed ID: 9255883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
    Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G
    J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
    Pfundstein J; Roghmann MC; Schwalbe RS; Qaiyumi SQ; McCarter RJ; Keay S; Schweitzer E; Bartlett ST; Morris JG; Oldach DW
    Clin Transplant; 1999 Jun; 13(3):245-52. PubMed ID: 10383105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
    Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
    Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
    J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
    Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
    J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.